QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
TSE:ARR

Altius Renewable Royalties (ARR) Stock Price, News & Analysis

C$9.38
-0.22 (-2.29%)
(As of 03:49 PM ET)
Today's Range
C$9.20
C$9.71
50-Day Range
C$7.65
C$9.60
52-Week Range
C$6.60
C$9.75
Volume
40,929 shs
Average Volume
14,922 shs
Market Capitalization
C$288.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$11.90

Altius Renewable Royalties MarketRank™ Stock Analysis

Analyst Rating
Buy
3.20 Rating Score
Upside/​Downside
26.9% Upside
C$11.90 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.36mentions of Altius Renewable Royalties in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.46 out of 5 stars

ARR stock logo

About Altius Renewable Royalties Stock (TSE:ARR)

Altius Renewable Royalties Corp., a renewable energy royalty company, engages in the acquisition and management of renewable energy investments and royalties in North America. The company holds interests in a portfolio of 2,068 MW of operational wind, solar, and hydroelectric projects located in Texas, Kansas, California, and Vermont. It also holds royalty interests related to a portfolio of approximately 5.5 GW of development stage wind and solar energy projects located across the United States; and 700 MW of wind projects under construction. Altius Renewable Royalties Corp. was incorporated in 2018 and is headquartered in St. John's, Canada. Altius Renewable Royalties Corp. is a subsidiary of Altius Minerals Corporation.

ARR Stock Price History

ARR Stock News Headlines

TSX:ARR (Altius Renewable Royalties)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
ARR:CA Altius Renewable Royalties Corp.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
TD Securities Remains a Buy on Altius Renewable Royalties (ARR)
See More Headlines
Receive ARR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Altius Renewable Royalties and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/06/2024
Today
4/19/2024
Next Earnings (Estimated)
5/03/2024

Industry, Sector and Symbol

Sector
Utilities
Industry
Utilities - Renewable
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$11.90
High Stock Price Target
C$13.00
Low Stock Price Target
C$11.00
Potential Upside/Downside
+24.0%
Consensus Rating
Buy
Rating Score (0-4)
3.20
Research Coverage
5 Analysts

Profitability

Net Income
C$-1,070,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$2.67 million
Cash Flow
C$2.23 per share
Book Value
C$6.67 per share

Miscellaneous

Free Float
N/A
Market Cap
C$295.58 million
Optionable
Not Optionable
Beta
0.96
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Brian Francis Dalton (Age 51)
    Chief Executive Officer
  • Mr. Benjamin Gerard Lewis B.Comm. (Age 56)
    CA, CPA, Chief Financial Officer
  • Mr. Peter Leahey
    Managing Director
  • Mr. Zachary Farrar
    Managing Director of Origination
  • Ms. Flora Wood B.A.
    M.A., Corporate Secretary

ARR Stock Analysis - Frequently Asked Questions

Should I buy or sell Altius Renewable Royalties stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Altius Renewable Royalties in the last year. There are currently 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ARR shares.
View ARR analyst ratings
or view top-rated stocks.

What is Altius Renewable Royalties' stock price target for 2024?

5 analysts have issued twelve-month price objectives for Altius Renewable Royalties' stock. Their ARR share price targets range from C$11.00 to C$13.00. On average, they anticipate the company's stock price to reach C$11.90 in the next year. This suggests a possible upside of 26.9% from the stock's current price.
View analysts price targets for ARR
or view top-rated stocks among Wall Street analysts.

How have ARR shares performed in 2024?

Altius Renewable Royalties' stock was trading at C$7.68 at the beginning of 2024. Since then, ARR stock has increased by 22.1% and is now trading at C$9.38.
View the best growth stocks for 2024 here
.

When is Altius Renewable Royalties' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 3rd 2024.
View our ARR earnings forecast
.

How were Altius Renewable Royalties' earnings last quarter?

Altius Renewable Royalties Corp. (TSE:ARR) announced its quarterly earnings results on Wednesday, March, 6th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company earned $1.32 million during the quarter, compared to analysts' expectations of $0.62 million. Altius Renewable Royalties had a negative net margin of 40.19% and a negative trailing twelve-month return on equity of 0.54%.

How do I buy shares of Altius Renewable Royalties?

Shares of ARR stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:ARR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners